Want to see TSE:DR full AI Analyst Report?
Medical Facilities (DR) Stock Price & Analysis
DR Stock Chart & Stats
- Day’s Range
- CAD 14.56 - CAD 14.93
- 52-Week Range
- CAD 13.59 - CAD 18.79
- Previous Close
- CAD 14.68
- Volume
- N/A
- Average Volume (3M)
- 17.65K
- Market Cap
- CAD 237.42M
- Enterprise Value
- CAD 321.35M
- Total Cash (Recent Filing)
- CAD 64.01M
- Total Debt (Recent Filing)
- CAD 54.60M
- Price to Earnings (P/E)
- 8.3
- Beta
- 0.43
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- 0.17
- Last Dividend Ex-Date
- Oct 01, 2026
- Dividend Yield
- 2.42%
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
Strong operating and free cash flow, with free cash flow closely supported by earnings, demonstrates effective cash conversion. This provides funding for operations, strategic needs, debt resilience and shareholder distributions over the next several quarters.
Healthy Liquidity And Lower Leverage
A substantial cash balance, increased working capital and the absence of corporate-level bank debt improve financial flexibility. This reduces refinancing exposure and gives management more capacity to support facilities and return capital.
Improved Profitability
Healthy current margins indicate that the facility portfolio can generate meaningful operating earnings from its surgical services. Improved profitability creates a stronger base for cash generation, although sustaining it depends on volumes and case mix.
Bears Say
Revenue Contraction And Volatility
The recent top-line contraction and history of sharp revenue and margin swings reduce earnings visibility. Persistent volatility could weaken operating leverage and make cash generation less predictable if procedure growth does not recover.
Surgical Volume Weakness
Weakness in several procedure categories threatens the volume foundation of facility revenue. Physician recruitment may help rebuild demand, but recovery is not assured, leaving results exposed to lower utilization and an unfavorable service mix.
Rising Operating Costs
Cost growth is pressuring the economics of surgical facilities, particularly through supplies and labor. If expense inflation persists faster than reimbursement or procedure growth, margins and free cash flow could face sustained pressure.
DR FAQ
What was Medical Facilities’s price range in the past 12 months?
What is Medical Facilities’s market cap?
When is Medical Facilities’s upcoming earnings report date?
How were Medical Facilities’s earnings last quarter?
Is Medical Facilities overvalued?
Does Medical Facilities pay dividends?
What is Medical Facilities’s EPS estimate?
How many shares outstanding does Medical Facilities have?
What happened to Medical Facilities’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Medical Facilities?
What is the TipRanks Smart Score and how is it calculated?
Medical Facilities Stock Smart Score
Company Description
Medical Facilities
Medical Facilities Corporation (MFC) is engaged in the ownership and management of a network of specialized surgical hospitals and an outpatient surgery facility across the United States. These surgical hospitals deliver a comprehensive range of medical services, encompassing various surgical procedures, diagnostic imaging, general diagnostics, and pain management interventions. Additionally, they provide supplementary services such as immediate care and workplace health. The company's ambulatory surgery center is specifically designed for performing scheduled surgical operations that do not require an overnight stay. MFC was established in 2004 and maintains its corporate headquarters in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jason Redman
- Employees
- 1,721
- Website
- www.medicalfacilitiescorp.ca
- Address
- 4576 Yonge Street, Toronto, ON, M2N 6N4, CA
Medical Facilities (DR) Earnings & Revenues
DR Earnings Call
Earnings Call SentimentPositive
The call presented a generally positive operational and financial update: revenue, income from operations, and EBITDA all grew year-over-year, liquidity is strong with no corporate-level debt, and shareholder returns remain substantial via buybacks. However, the company faces notable volume softness in certain categories (inpatient, observation, pain management), and operating costs rose materially, which temper the outlook. Overall the positives—top-line and profit growth, strong cash position, and committed capital returns—outweigh the headwinds from volume mix and expense pressures.
View all TSE:DR earnings summariesDR Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 10 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 4 | 0 | 8 |
